2015
DOI: 10.1038/nature14592
|View full text |Cite
|
Sign up to set email alerts
|

Engineered CRISPR-Cas9 nucleases with altered PAM specificities

Abstract: Although CRISPR-Cas9 nucleases are widely used for genome editing1, 2, the range of sequences that Cas9 can recognize is constrained by the need for a specific protospacer adjacent motif (PAM)3–6. As a result, it can often be difficult to target double-stranded breaks (DSBs) with the precision that is necessary for various genome editing applications. The ability to engineer Cas9 derivatives with purposefully altered PAM specificities would address this limitation. Here we show that the commonly used Streptoco… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

30
1,128
3
8

Year Published

2016
2016
2022
2022

Publication Types

Select...
5
4
1

Relationship

1
9

Authors

Journals

citations
Cited by 1,408 publications
(1,169 citation statements)
references
References 36 publications
30
1,128
3
8
Order By: Relevance
“…Nuclease variants were generated by isothermal assembly into JDS246 (Addgene #43861) 5 , and guide RNAs were cloned into BsmB I-digested BPK1520 (Addgene #65777) 25 . Both U2OS cells (a gift from T. Cathomen, Freiburg) and U2OS-EGFP cells (encoding a single integrated copy of a pCMV-EGFP–PEST cassette) 26 were cultured at 37 °C with 5% CO 2 in advanced DMEM containing 10% heat-inactivated fetal bovine serum, 2 mM GlutaMax, penicillin/streptomycin, and 400 µg ml −1 Geneticin (for U2OS-EGFP cells only).…”
Section: Methodsmentioning
confidence: 99%
“…Nuclease variants were generated by isothermal assembly into JDS246 (Addgene #43861) 5 , and guide RNAs were cloned into BsmB I-digested BPK1520 (Addgene #65777) 25 . Both U2OS cells (a gift from T. Cathomen, Freiburg) and U2OS-EGFP cells (encoding a single integrated copy of a pCMV-EGFP–PEST cassette) 26 were cultured at 37 °C with 5% CO 2 in advanced DMEM containing 10% heat-inactivated fetal bovine serum, 2 mM GlutaMax, penicillin/streptomycin, and 400 µg ml −1 Geneticin (for U2OS-EGFP cells only).…”
Section: Methodsmentioning
confidence: 99%
“…Also, as we have shown, adjustments to the target sequences and dosages of editing reagents can be used to fine-tune mutation rates and to minimize undesirable intertarget deletions. Finally, sgRNA sequences and lengths (31), Cas9 cleavage activity and target preferences (32,33), and the means by which Cas9 and sgRNA(s) are expressed (e.g. transient, constitutive (34), or induced (35,36)), can be altered to control the pace, temporal window and tissue(s) at which the barcodes are mutated.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, fusing Cas9 to DNA-binding domains has also proven effective at improving its specificity (Bolukbasi et al 2015). Finally, several studies have recently showed that protein engineering can broadly enhance Cas9 specificity (Kleinstiver et al 2016;Slaymaker et al 2016) and even alter its PAM requirements (Kleinstiver et al 2015), the latter having the potential to enable creation of customized variants of Cas9 for allele-specific gene editing, although Cas9 orthologs Esvelt et al 2013;Hou et al 2013;Ran et al 2015) or alternative CRISPR systems (Zetsche et al 2015a) with unique PAM specificities have been uncovered in nature.…”
Section: Crispr-cas9mentioning
confidence: 99%